MYUNGMOON Pharm Co., Ltd. (017180) Ratios

― Followers

MYUNGMOON Pharm Co., Ltd. Ratios

KR:017180's free cash flow for Q2 2026 was ₩0.60. For the 2026 fiscal year, KR:017180's free cash flow was decreased by ₩ and operating cash flow was ₩-0.02. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.06	0.96	0.87	0.70	0.64
Quick Ratio	0.67	0.55	0.51	0.44	0.41
Cash Ratio	0.22	0.06	0.05	0.07	0.04
Solvency Ratio	<0.01	0.03	<0.01	>-0.01	0.09
Operating Cash Flow Ratio	-0.03	-0.02	-0.01	-0.04	0.05
Short-Term Operating Cash Flow Coverage	-0.05	-0.03	-0.03	-0.07	0.07
Net Current Asset Value	₩ -79.11B	₩ -75.93B	₩ -74.54B	₩ -66.36B	₩ -64.48B
Leverage Ratios
Debt-to-Assets Ratio	0.29	0.36	0.34	0.38	0.36
Debt-to-Equity Ratio	0.89	1.00	0.90	1.08	0.93
Debt-to-Capital Ratio	0.47	0.50	0.47	0.52	0.48
Long-Term Debt-to-Capital Ratio	0.18	0.30	0.27	0.13	0.06
Financial Leverage Ratio	3.08	2.76	2.66	2.83	2.57
Debt Service Coverage Ratio	0.06	0.15	0.10	0.05	0.20
Interest Coverage Ratio	0.32	1.34	0.36	0.19	1.72
Debt to Market Cap	2.10	1.56	1.43	1.09	0.77
Interest Debt Per Share	2.75K	3.05K	2.77K	2.84K	2.57K
Net Debt to EBITDA	13.64	9.16	14.65	18.23	7.41
Profitability Margins
Gross Profit Margin	57.27%	54.90%	56.30%	56.23%	51.34%
EBIT Margin	0.98%	3.50%	0.86%	0.21%	4.20%
EBITDA Margin	2.31%	5.19%	3.04%	2.67%	6.95%
Operating Profit Margin	0.76%	3.50%	1.03%	0.57%	4.23%
Pretax Profit Margin	-1.18%	1.36%	-2.01%	-2.82%	1.74%
Net Profit Margin	-0.83%	0.97%	-1.63%	-2.67%	5.17%
Continuous Operations Profit Margin	-1.28%	0.73%	-2.03%	-2.87%	5.24%
Net Income Per EBT	70.66%	71.58%	81.04%	94.63%	296.66%
EBT Per EBIT	-155.04%	38.74%	-194.14%	-496.14%	41.22%
Return on Assets (ROA)	-0.56%	0.70%	-1.18%	-1.91%	3.41%
Return on Equity (ROE)	-1.70%	1.92%	-3.13%	-5.42%	8.79%
Return on Capital Employed (ROCE)	0.81%	3.88%	1.17%	0.80%	5.38%
Return on Invested Capital (ROIC)	0.60%	1.58%	0.89%	0.49%	3.29%
Return on Tangible Assets	-0.56%	0.70%	-1.18%	-1.92%	3.42%
Earnings Yield	-4.07%	3.02%	-4.98%	-5.55%	7.53%
Efficiency Ratios
Receivables Turnover	4.01	4.19	4.42	5.06	5.16
Payables Turnover	4.60	5.73	4.69	4.43	4.72
Inventory Turnover	1.95	2.27	2.49	2.45	2.89
Fixed Asset Turnover	1.47	1.18	1.15	1.21	1.07
Asset Turnover	0.67	0.72	0.72	0.72	0.66
Working Capital Turnover Ratio	223.40	-23.49	-7.89	-4.52	-3.55
Cash Conversion Cycle	198.78	183.79	151.11	138.65	119.89
Days of Sales Outstanding	90.94	87.02	82.56	72.09	70.67
Days of Inventory Outstanding	187.12	160.51	146.42	148.93	126.51
Days of Payables Outstanding	79.28	63.75	77.87	82.36	77.29
Operating Cycle	278.06	247.54	228.98	221.01	197.18
Cash Flow Ratios
Operating Cash Flow Per Share	-106.24	-50.19	-39.95	-153.82	161.95
Free Cash Flow Per Share	-296.42	-249.23	-81.85	-242.62	104.33
CapEx Per Share	190.19	199.05	41.90	88.80	57.62
Free Cash Flow to Operating Cash Flow	2.79	4.97	2.05	1.58	0.64
Dividend Paid and CapEx Coverage Ratio	-0.56	-0.25	-0.95	-1.73	2.81
Capital Expenditure Coverage Ratio	-0.56	-0.25	-0.95	-1.73	2.81
Operating Cash Flow Coverage Ratio	-0.04	-0.02	-0.02	-0.06	0.07
Operating Cash Flow to Sales Ratio	-0.02	>-0.01	>-0.01	-0.03	0.04
Free Cash Flow Yield	-24.18%	-13.47%	-4.50%	-10.03%	3.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-20.40	32.63	-20.07	-18.01	13.28
Price-to-Sales (P/S) Ratio	0.21	0.32	0.33	0.48	0.69
Price-to-Book (P/B) Ratio	0.42	0.64	0.63	0.98	1.17
Price-to-Free Cash Flow (P/FCF) Ratio	-4.15	-7.42	-22.22	-9.97	29.62
Price-to-Operating Cash Flow Ratio	-11.59	-36.86	-45.53	-15.73	19.08
Price-to-Earnings Growth (PEG) Ratio	0.08	-0.20	0.62	0.11	-0.06
Price-to-Fair Value	0.42	0.64	0.63	0.98	1.17
Enterprise Value Multiple	22.54	15.36	25.39	36.24	17.29
Enterprise Value	104.05B	155.61B	144.02B	164.02B	182.76B
EV to EBITDA	22.50	15.36	25.39	36.24	17.29
EV to Sales	0.52	0.80	0.77	0.97	1.20
EV to Free Cash Flow	-10.50	-18.39	-52.55	-20.07	51.82
EV to Operating Cash Flow	-29.30	-91.32	-107.66	-31.66	33.38
Tangible Book Value Per Share	3.06K	3.06K	3.06K	2.63K	2.81K
Shareholders’ Equity Per Share	2.92K	2.91K	2.89K	2.48K	2.65K
Tax and Other Ratios
Effective Tax Rate	-0.09	0.46	-0.01	-0.02	-2.01
Revenue Per Share	5.98K	5.75K	5.57K	5.03K	4.50K
Net Income Per Share	-49.91	55.82	-90.62	-134.35	232.74
Tax Burden	0.71	0.72	0.81	0.95	2.97
Interest Burden	-1.20	0.39	-2.33	-13.44	0.42
Research & Development to Revenue	0.03	0.05	0.01	0.02	0.01
SG&A to Revenue	0.44	0.39	0.44	0.43	0.31
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	1.99	-0.90	0.35	1.14	0.69

Currency in KRW